[1]
|
Pritam, P., Deka, R., Bhardwaj, A., et al. (2022) Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology (Basel), 11, 212. https://doi.org/10.3390/biology11020212
|
[2]
|
Matthews, K.A., Xu, W., Gaglioti, A.H., et al. (2019) Racial and Ethnic Estimates of Alzheimer’s Disease and Related Dementias in the United States (2015-2060) in Adults Aged >/=65 Years. Alzheimer’s & Dementia, 15, 17-24.
https://doi.org/10.1016/j.jalz.2018.06.3063
|
[3]
|
Stern, Y. (2012) Cognitive Reserve in Ageing and Alzheimer’s Disease. The Lancet Neurology, 11, 1006-1012.
https://doi.org/10.1016/S1474-4422(12)70191-6
|
[4]
|
GBD (2019) Global, Regional, and National Burden of Neurological Disorders, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18, 459-480.
https://doi.org/10.1016/S1474-4422(18)30499-X
|
[5]
|
Hachinski, V., Einhaupl, K., Ganten, D., et al. (2019) Preventing Dementia by Preventing Stroke: The Berlin Manifesto. Alzheimer’s & Dementia, 15, 961-984. https://doi.org/10.1016/j.jalz.2019.06.001
|
[6]
|
Sanchez-Muniz, F.J., Macho-Gonzalez, A., Garcimartin, A., et al. (2019) The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer’s Disease. Nutrients, 11, 1558.
https://doi.org/10.3390/nu11071558
|
[7]
|
王星, 崔宇, 刘晶晶, 等. 阿尔茨海默病与日常膳食的关系[J]. 中国食品学报, 2021, 21(6): 375-379.
|
[8]
|
李嘉毓, 张媛媛, 郭琪, 等. 阿尔茨海默病的地中海饮食模式干预进展[J]. 现代临床护理, 2021, 20(7): 76-81.
|
[9]
|
Cummings, J.L., Tong, G. and Ballard, C. (2019) Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options. Journal of Alzheimer’s Disease, 67, 779-794. https://doi.org/10.3233/JAD-180766
|
[10]
|
Khan, S., Barve, K.H. and Kumar, M.S. (2020) Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease. Current Neuropharmacology, 18, 1106-1125.
https://doi.org/10.2174/1570159X18666200528142429
|
[11]
|
李苏垚, 王玉银, 魏文悦, 等. 阿尔兹海默病的发病机制及其先天免疫性/适应性免疫研究. 山西大同大学学报(自然科学版), 2021, 37(6): 86-89.
|
[12]
|
Kempuraj, D., Ahmed, M.E., Selvakumar, G.P., et al. (2020) Brain Injury-Mediated Neuroinflammatory Response and Alzheimer’s Disease. Neuroscientist, 26, 134-155. https://doi.org/10.1177/1073858419848293
|
[13]
|
Serrano-Pozo, A., Das, S. and Hyman, B.T. (2021) APOE and Alzheimer’s Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches. The Lancet Neurology, 20, 68-80.
https://doi.org/10.1016/S1474-4422(20)30412-9
|
[14]
|
Babcock, K.R., Page, J.S., Fallon, J.R., et al. (2021) Adult Hippocampal Neurogenesis in Aging and Alzheimer’s Disease. Stem Cell Reports, 16, 681-693. https://doi.org/10.1016/j.stemcr.2021.01.019
|
[15]
|
Bredesen, D.E., Amos, E.C., Canick, J., et al. (2016) Reversal of Cognitive Decline in Alzheimer’s Disease. Aging (Albany NY), 8, 1250-1258. https://doi.org/10.18632/aging.100981
|
[16]
|
Agrawal, I. and Jha, S. (2020) Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia. Frontiers in Aging Neuroscience, 12, 252. https://doi.org/10.3389/fnagi.2020.00252
|
[17]
|
Pall, M.L. (2022) Low Intensity Electromagnetic Fields Act via Voltage-Gated Calcium Channel (VGCC) Activation to Cause Very Early Onset Alzheimer’s Disease: 18 Distinct Types of Evidence. Current Alzheimer Research, 19, 119-132. https://doi.org/10.2174/1567205019666220202114510
|
[18]
|
王建华, 刘桂芳, 冯亚青, 等. Alzheimer病的Aβ假说及血管性假说研究进展[J]. 脑与神经疾病杂志, 2005(6): 477-479.
|
[19]
|
Reeves, B.C., Karimy, J.K., Kundishora, A.J., et al. (2020) Glymphatic System Impairment in Alzheimer’s Disease and Idiopathic Normal Pressure Hydrocephalus. Trends in Molecular Medicine, 26, 285-295.
https://doi.org/10.1016/j.molmed.2019.11.008
|
[20]
|
Nanclares, C., Baraibar, A.M., Araque, A., et al. (2021) Dysregulation of Astrocyte-Neuronal Communication in Alzheimer’s Disease. International Journal of Molecular Sciences, 22, 7887. https://doi.org/10.3390/ijms22157887
|
[21]
|
张宁远, 郑锡军, 许羚, 等. 阿尔兹海默病的疾病进展模型与研究进展[J]. 中国临床药理学与治疗学, 2021, 26(6): 687-694.
|
[22]
|
王玉梅. 阿尔茨海默病发病机制Aβ假说的研究进展[J]. 中国临床研究, 2011, 24(11): 1042-1044.
|
[23]
|
马步勇. Aβ级联假说或tau蛋白假说, 哪个更正确?[J]. 上海交通大学学报, 2021, 55(S1): 58-59.
|
[24]
|
Edwards, G.R., Zhao, J., Dash, P.K., et al. (2020) Traumatic Brain Injury Induces Tau Aggregation and Spreading. Journal of Neurotrauma, 37, 80-92. https://doi.org/10.1089/neu.2018.6348
|
[25]
|
Tang, S.J., Fesharaki-Zadeh, A., Takahashi, H., et al. (2020) Fyn Kinase Inhibition Reduces Protein Aggregation, Increases Synapse Density and Improves Memory in Transgenic and Traumatic Tauopathy. Acta Neuropathologica Communications, 8, 96. https://doi.org/10.1186/s40478-020-00976-9
|
[26]
|
Zhang, F., Zhong, R.J., Cheng, C., et al. (2021) New Therapeutics beyond Amyloid-Beta and Tau for the Treatment of Alzheimer’s Disease. Acta Pharmacologica Sinica, 42, 1382-1389. https://doi.org/10.1038/s41401-020-00565-5
|
[27]
|
Minter, M.R., Taylor, J.M. and Crack, P.J. (2016) The Contribution of Neuroinflammation to Amyloid Toxicity in Alzheimer’s Disease. Journal of Neurochemistry, 136, 457-474. https://doi.org/10.1111/jnc.13411
|
[28]
|
Sinsky, J., Pichlerova, K. and Hanes, J. (2021) Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies. International Journal of Molecular Sciences, 22, 9207. https://doi.org/10.3390/ijms22179207
|
[29]
|
苏霄, 赵世刚, 赵婷婷, 等. 阿尔兹海默病发病机制的新进展[J]. 中华临床医师杂志(电子版), 2021, 15(3): 224-228.
|
[30]
|
Pervin, M., Unno, K., Takagaki, A., et al. (2019) Function of Green Tea Catechins in the Brain: Epigallocatechin Gallate and Its Metabolites. International Journal of Molecular Sciences, 20, 3630. https://doi.org/10.3390/ijms20153630
|
[31]
|
Sweeney, M.D., Sagare, A.P. and Zlokovic, B.V. (2018) Blood-Brain Barrier Breakdown in Alzheimer Disease and Other Neurodegenerative Disorders. Nature Reviews Neurology, 14, 133-150.
https://doi.org/10.1038/nrneurol.2017.188
|
[32]
|
Yin, F., Sancheti, H., Patil, I., et al. (2016) Energy Metabolism and Inflammation in Brain Aging and Alzheimer’s Disease. Free Radical Biology and Medicine, 100, 108-122. https://doi.org/10.1016/j.freeradbiomed.2016.04.200
|
[33]
|
Liccardo, D., Marzano, F., Carraturo, F., et al. (2020) Potential Bidirectional Relationship between Periodontitis and Alzheimer’s Disease. Frontiers in Physiology, 11, 683. https://doi.org/10.3389/fphys.2020.00683
|
[34]
|
Nunomura, A. and Perry, G. (2020) RNA and Oxidative Stress in Alzheimer’s Disease: Focus on microRNAs. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 2638130. https://doi.org/10.1155/2020/2638130
|
[35]
|
Wang, X., Wang, W., Li, L., et al. (2014) Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease. Biochimica et Biophysica Acta, 1842, 1240-1247. https://doi.org/10.1016/j.bbadis.2013.10.015
|
[36]
|
Rahman, M.A., Hannan, M.A., Uddin, M.J., et al. (2021) Exposure to Environmental Arsenic and Emerging Risk of Alzheimer’s Disease: Perspective Mechanisms, Management Strategy, and Future Directions. Toxics, 9, 188.
https://doi.org/10.3390/toxics9080188
|
[37]
|
Kamat, P.K., Kalani, A., Rai, S., et al. (2016) Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies. Molecular Neurobiology, 53, 648-661.
https://doi.org/10.1007/s12035-014-9053-6
|
[38]
|
Tonnies, E. and Trushina, E. (2017) Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 57, 1105-1121. https://doi.org/10.3233/JAD-161088
|
[39]
|
Awasthi, S., Hindle, A., Sawant, N.A., et al. (2021) RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease. Cells, 10, 3113. https://doi.org/10.3390/cells10113113
|
[40]
|
Pluta, R., Ulamek-Koziol, M., Januszewski, S., et al. (2020) Gut Microbiota and Pro/Prebiotics in Alzheimer’s Disease. Aging (Albany NY), 12, 5539-5550. https://doi.org/10.18632/aging.102930
|
[41]
|
Lotti-Mesa, R.L. and Gutierrez-Gacel, L. (2019) The Microbiota-Gut-Brain Axis, Future Therapeutic Target in Neurodegenerative Diseases. Revue Neurologique, 69, 43-44. https://doi.org/10.33588/rn.6901.2019159
|
[42]
|
Leclerc, M., Dudonne, S. and Calon, F. (2021) Can Natural Products Exert Neuroprotection without Crossing the Blood-Brain Barrier? International Journal of Molecular Sciences, 22, 3356. https://doi.org/10.3390/ijms22073356
|
[43]
|
Ghaisas, S., Maher, J. and Kanthasamy, A. (2016) Gut Microbiome in Health and Disease: Linking the Microbiome-Gut-Brain Axis and Environmental Factors in the Pathogenesis of Systemic and Neurodegenerative Diseases. Pharmacology & Therapeutics, 158, 52-62. https://doi.org/10.1016/j.pharmthera.2015.11.012
|
[44]
|
Sochocka, M., Donskow-Lysoniewska, K., Diniz, B.S., et al. (2019) The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—A Critical Review. Molecular Neurobiology, 56, 1841-1851.
https://doi.org/10.1007/s12035-018-1188-4
|
[45]
|
Shabbir, U., Arshad, M.S., Sameen, A., et al. (2021) Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies. Nutrients, 13, 690. https://doi.org/10.3390/nu13020690
|
[46]
|
Akter, R., Afrose, A., Rahman, M.R., et al. (2021) A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer’s Disease, Aging, Cancer, Inflammation, and Diabetes. International Journal of Molecular Sciences, 22, 4180. https://doi.org/10.3390/ijms22084180
|
[47]
|
Gruendler, R., Hippe, B., Sendula, J.V., et al. (2020) Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer’s Disease: A Systematic Review. Molecules, 25, 6018. https://doi.org/10.3390/molecules25246018
|
[48]
|
Davinelli, S., Sapere, N., Zella, D., et al. (2012) Pleiotropic Protective Effects of Phytochemicals in Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity, 2012, Article ID: 386527. https://doi.org/10.1155/2012/386527
|
[49]
|
刘彦霞, 黄汉昌, 常平, 等. 儿茶素类物质在阿尔茨海默病中的神经保护作用机制[J]. 天然产物研究与开发, 2013, 25(11): 1607-1613.
|
[50]
|
Musial, C., Kuban-Jankowska, A. and Gorska-Ponikowska, M. (2020) Beneficial Properties of Green Tea Catechins. International Journal of Molecular Sciences, 21, 1744. https://doi.org/10.3390/ijms21051744
|
[51]
|
Pervin, M., Unno, K., Ohishi, T., et al. (2018) Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases. Molecules, 23, 1297. https://doi.org/10.3390/molecules23061297
|
[52]
|
Prasanth, M.I., Sivamaruthi, B.S., Chaiyasut, C., et al. (2019) A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy. Nutrients, 11, 474.
https://doi.org/10.3390/nu11020474
|
[53]
|
Acharya, A., Stockmann, J., Beyer, L., et al. (2020) The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-beta Secondary Structure. Biophysical Journal, 119, 349-359. https://doi.org/10.1016/j.bpj.2020.05.033
|
[54]
|
Jiang, L., Zhao, J., Cheng, J.X., et al. (2020) Tau Oligomers and Fibrils Exhibit Differential Patterns of Seeding and Association with RNA Binding Proteins. Frontiers in Neurology, 11, Article ID: 579434.
https://doi.org/10.3389/fneur.2020.579434
|
[55]
|
Wobst, H.J., Sharma, A., Diamond, M.I., et al. (2015) The Green Tea Polyphenol (-)-epigallocatechin Gallate Prevents the Aggregation of Tau Protein into Toxic Oligomers at Substoichiometric Ratios. FEBS Letters, 589, 77-83.
https://doi.org/10.1016/j.febslet.2014.11.026
|
[56]
|
Okello, E.J. and Mather, J. (2020) Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer’s Disease. Nutrients, 12, 1090.
https://doi.org/10.3390/nu12041090
|
[57]
|
Hussain, T., Tan, B., Yin, Y., et al. (2016) Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxidative Medicine and Cellular Longevity, 2016, Article ID: 7432797. https://doi.org/10.1155/2016/7432797
|
[58]
|
Forman, H.J. and Zhang, H. (2021) Targeting Oxidative Stress in Disease: Promise and Limitations of Antioxidant Therapy. Nature Reviews Drug Discovery, 20, 689-709. https://doi.org/10.1038/s41573-021-00233-1
|
[59]
|
Adami, G.R., Tangney, C. and Schwartz, J.L., et al. (2020) Gut/Oral Bacteria Variability May Explain the High Efficacy of Green Tea in Rodent Tumor Inhibition and Its Absence in Humans. Molecules, 25, 4753.
https://doi.org/10.3390/molecules25204753
|
[60]
|
Poljsak, B., Suput, D. and Milisav, I. (2013) Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants. Oxidative Medicine and Cellular Longevity, 2013, Article ID: 956792.
https://doi.org/10.1155/2013/956792
|
[61]
|
Malaguarnera, L. (2019) Influence of Resveratrol on the Immune Response. Nutrients, 11, 946.
https://doi.org/10.3390/nu11050946
|
[62]
|
Gomes, B., Silva, J., Romeiro, C., et al. (2018) Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1. Oxidative Medicine and Cellular Longevity, 2018, Article ID: 8152373.
https://doi.org/10.1155/2018/8152373
|
[63]
|
左灵燕, 朱冯婷, 帅红艳, 等. 白藜芦醇及其代谢产物治疗阿尔茨海默病的研究进展[J]. 国际神经病学神经外科学杂志, 2021, 48(4): 382-386.
|
[64]
|
Jia, Y., Wang, N. and Liu, X. (2017) Resveratrol and Amyloid-Beta: Mechanistic Insights. Nutrients, 9, 1122.
https://doi.org/10.3390/nu9101122
|
[65]
|
Meng, T., Xiao, D., Muhammed, A., et al. (2021) Anti-Inflammatory Action and Mechanisms of Resveratrol. Molecules, 26, 229. https://doi.org/10.3390/molecules26010229
|
[66]
|
Li, Y., Zhang, J., Wan, J., et al. (2020) Melatonin Regulates Abeta Production/Clearance Balance and Abeta Neurotoxicity: A Potential Therapeutic Molecule for Alzheimer’s Disease. Biomedicine & Pharmacotherapy, 132, Article ID: 110887. https://doi.org/10.1016/j.biopha.2020.110887
|
[67]
|
Lyu, Z., Chan, Y., Li, Q., et al. (2021) Destructive Effects of Pyroptosis on Homeostasis of Neuron Survival Associated with the Dysfunctional BBB-Glymphatic System and Amyloid-Beta Accumulation after Cerebral Ischemia/Reperfusion in Rats. Neural Plasticity, 2021, Article ID: 4504363. https://doi.org/10.1155/2021/4504363
|
[68]
|
Yang, A., Bagit, A. and Macpherson, R. (2021) Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease. International Journal of Molecular Sciences, 22, 4628.
https://doi.org/10.3390/ijms22094628
|
[69]
|
Ai, Z., Li, C., Li, L., et al. (2015) Resveratrol Inhibits Beta-Amyloid-Induced Neuronal Apoptosis via Regulation of p53 Acetylation in PC12 Cells. Molecular Medicine Reports, 11, 2429-2434. https://doi.org/10.3892/mmr.2014.3034
|
[70]
|
李娟, 聂晶, 张敏. 姜黄素对阿尔茨海默病(AD)模型大鼠的抗痴呆作用研究[J]. 医学研究杂志, 2013, 42(6): 173-176.
|
[71]
|
Chainoglou, E. and Hadjipavlou-Litina, D. (2020) Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids. International Journal of Molecular Sciences, 21, 1975.
https://doi.org/10.3390/ijms21061975
|
[72]
|
郗红娟. 姜黄素在阿尔茨海默病中相关作用机制的研究[J]. 生物技术世界, 2015(9): 83.
|
[73]
|
杨融辉, 张宁. 姜黄素对阿尔茨海默病作用机制的研究进展[J]. 东南大学学报(医学版), 2015, 34(1): 152-155.
|
[74]
|
张莉莉, 査晓明, 楼影涵, 等. 姜黄素对阿尔茨海默病中Aβ诱导的神经毒性保护作用的研究进展[J]. 亚太传统医药, 2012, 8(8): 199-201.
|
[75]
|
Goozee, K.G., Shah, T.M., Sohrabi, H.R., et al. (2016) Examining the Potential Clinical Value of Curcumin in the Prevention and Diagnosis of Alzheimer’s Disease. British Journal of Nutrition, 115, 449-465.
https://doi.org/10.1017/S0007114515004687
|
[76]
|
陈娟丽, 魏传飞, 韩发彬. 姜黄素改善阿尔茨海默病认知和记忆功能的研究进展[J]. 中国老年学杂志, 2021, 41(4): 887-891.
|
[77]
|
林文娟, 尹大川. 姜黄素抑制TAU蛋白聚集治疗阿尔茨海默症的研究进展[J]. 当代医学, 2021, 27(9): 190-194.
|
[78]
|
Pluta, R., Ulamek-Koziol, M. and Czuczwar, S.J. (2018) Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer’s Disease Phenotype. International Journal of Molecular Sciences, 19, 4002. https://doi.org/10.3390/ijms19124002
|